NKTX | Complete Nkarta Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
NKTX | Complete Nkarta Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
View Nkarta (NKTX) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Trade commission-free with the Futubull stock trading app.
NASDAQ: EDIT Editas Medicine Market Cap $287M Current Price $3.48 NASDAQ: ABCL AbCellera Biologics Market Cap $769M Current Price $2.61 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...
Find the latest institutional holdings data for Nkarta, Inc. Common Stock (NKTX) including shareholders, ownership summaries, and holding activities at Nasdaq.com.
Nkarta, Inc. Common Stock (NKTX) Revenue EPS <过去三年 未来三年> ©2023 OTC Markets Group EDGAR®Online 部门版权所有。EDGAR® 是美国证券交易监督委员会的联邦注册商标。EDGAR Online 不隶属于美国证券交易监督委员会,也不需要经其批准。
Review quarterly and annual revenue, net income, and cash flow for Nkarta Inc Ordinary Shares (NKTX:XNAS) stock through the last fiscal year.
Home Stock Analysis Market News Market Data Dividends ETFs Education Podcasts Videos Investing Groups Explore Investing Groups Portfolios About Premium Create free account Log in NKTXNkarta, Inc. Profitability Metrics 4.64K followers $3.900.06(+1.56%)4:00 PM 10/08/24 ...
3.980 +0.040+1.02% 盘后20:02 (美东) 2.78亿总市值-2000市盈率TTM 4.100最高价3.855最低价66.52万股成交量4.020今开3.900昨收263.46万成交额1.91%换手率亏损市盈率(静)7055.88万总股本16.24052周最高0.61市净率1.37亿流通值1.45052周最低--股息TTM3489.57万流通股79.160历史最高--股息率TTM6.28%振幅1.280历史最低...
加拿大投资银行集团:维持Nkarta(NKTX.US)评级,由买入调整至买入评级, 目标价由16.00美元调整至15.00美元。 Nkarta(NKTX.US)公司简介:Nkarta Inc 是一家生物制药公司,致力于开发用于治疗癌症的工程化自然杀伤 (NK) 细胞。 该公司致力于利用 NK 细胞的天然强大力量来识别和杀死异常细胞,并招募适应性免疫效应器以产...